Search

Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2021

The Benefits of Anti-VEGF for Advanced Vision Loss in Wet AMD

Dennis Han, MD; Timothy G. Murray, MD

Show Description +

Dennis Han, MD, explains why patients with advanced vision loss due to wet AMD may still garner significant benefit from treatment with anti-VEGF.

Posted: 2/23/2021

Keywords:

Wet AMD

•

Anti-VEGF

•

retina-meeting-recap

•

Vision Loss

Up Next

Diabetic Retinopathy: Treat Them Early

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

An Update on Surgical Approaches to Gene and Cell Therapies

An Update on Surgical Approaches to Gene and Cell Therapies

Allen C. Ho, MD, Timothy G. Murray, MD, MBA

ROP in the Era of Anti-VEGF

ROP in the Era of Anti-VEGF

R.V. Paul Chan, MD, MSc, MBA, FACS, Timothy G. Murray, MD, MBA

Advancements in Retinal Detachment Repair

Advancements in Retinal Detachment Repair

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

The Promise of Macular Reconstruction

Timothy W. Olsen, MD, Timothy G. Murray, MD, MBA

An Update on Brolucizumab One Year Later

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Back to All Videos

The Benefits of Anti-VEGF for Advanced Vision Loss in Wet AMD

Dennis Han, MD; Timothy G. Murray, MD

Dennis Han, MD, explains why patients with advanced vision loss due to wet AMD may still garner significant benefit from treatment with anti-VEGF.

Posted: 2/23/2021

Keywords:

Wet AMD

•

Anti-VEGF

•

retina-meeting-recap

•

Vision Loss

Please log in to leave a comment.

More From ARDS: 2021 Coverage

An Update on Brolucizumab One Year Later

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Track the History–and Future–of Anti-VEGF

Robert Avery, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA

Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ARDS: 2021.